États-Unis · Plateformes & données · Yahoo Finance

ELUCIDATE Study Demonstrates 93 Percent Accuracy with Strong Performance in the "Gray Zone" for Elucid’s FDA-cleared FFR-IQ™

Publié par Yahoo Finance · États-Unis il y a 9 h

BOSTON & SAN DIEGO, November 03, 2026--(BUSINESS WIRE)--Elucid, an innovator of AI-powered cardiovascular imaging software, today announced results from ELUCIDATE, presented at…

Lire l'article complet sur Yahoo Finance Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (finance.yahoo.com)

ELUCIDATE Study Demonstrates 93 Percent Accuracy with Strong Performance in the "Gray Zone" for Elucid’s FDA-cleared FFR-IQ™

À lire aussi

Offerpad (OPAD) Q3 2026 Earnings Call Transcript

Delta blasts a Heathrow Airport operational decision

Axa Sa (OTCMKTS:AXAHY) Stock Now Rated "Moderate Buy" by Wall Street Brokerages

3 signs cash-strapped consumers are nearing a ‘spend-pocalypse’ that would hurt the economy

Taco Bell sales fall more than expected on cyclosporiasis outbreak hit

Best Biotech Stocks Right Now

ELUCIDATE Study Demonstrates 93 Percent Accuracy with Strong Performance in the "Gray Zone" for Elucid’s FDA-cleared FFR-IQ™

Partager

À lire aussi

Offerpad (OPAD) Q3 2026 Earnings Call Transcript

Delta blasts a Heathrow Airport operational decision

Axa Sa (OTCMKTS:AXAHY) Stock Now Rated "Moderate Buy" by Wall Street Brokerages

3 signs cash-strapped consumers are nearing a ‘spend-pocalypse’ that would hurt the economy

Taco Bell sales fall more than expected on cyclosporiasis outbreak hit

Best Biotech Stocks Right Now